IRMD (iRadimed) Additional Paid-In Capital : $30.74 Mil(As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is iRadimed Additional Paid-In Capital?

iRadimed's quarterly additional paid-in capital increased from Sep. 2024 ($29.89 Mil) to Dec. 2024 ($30.03 Mil) and increased from Dec. 2024 ($30.03 Mil) to Mar. 2025 ($30.74 Mil).

iRadimed's annual additional paid-in capital increased from Dec. 2022 ($26.41 Mil) to Dec. 2023 ($28.16 Mil) and increased from Dec. 2023 ($28.16 Mil) to Dec. 2024 ($30.03 Mil).

iRadimed Additional Paid-In Capital Historical Data

The historical data trend for iRadimed's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRadimed Additional Paid-In Capital Chart

iRadimed Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Additional Paid-In Capital

Get a 7-Day Free Trial

23.68

25.16

26.41

28.16

30.03

iRadimed Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Additional Paid-In Capital	Get a 7-Day Free Trial															28.73	29.27	29.89	30.03	30.74

iRadimed Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

iRadimed Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of iRadimed's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

iRadimed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRadimed Corp (NAS:IRMD) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

46K:Germany 46K:Germany

Address

1025 Willa Springs Drive, Winter Springs, FL, USA, 32708

Website

https://www.iradimed.com

iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

Executives

John Glenn	officer: Chief Financial Officer	7900 HOPYARD ROAD, APT 210, PLEASANTON CA 94577
Anthony Vuoto	director
Monty K Allen	director
Roger E. Susi	director, 10 percent owner, officer: CEO, President, Chairman	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
James B Hawkins	director	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Hilda Frederique Scharen-guivel	director	440 PALM ISLAND SE, CLEARWATER BEACH FL 33767
Christopher K. Scott	officer: CHIEF FINANCIAL OFFICER & SECR	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Brent Johnson	officer: Exec. VP. Sales & Marketing	4900 HOPYARD RD, SUITE 210, PLEASITAN CA 94588
Steven M. Nardi	officer: VP MANUFACTURING	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Louis S. Waldman	officer: CONTROLLER	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
Leslie L Mcdonnell	director, officer: Chief Exec Officer & Director	1501 INDUSTRIAL ROAD, SAN CARLOS CA 94070
Francis X. Casey	officer: VP OF REG AND QUAL ASSURANCE	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708
John K Mccreery	officer: Chief Operating Officer	IRADIMED CORP, 1025 WILLA SPRINGS BLVD, WINTER SPRINGS FL 32708
Jonathan Kennedy	director	INTERSIL CORPORATION, 1001 MURPHY RANCH ROAD, MILPITAS CA 95035
Serge Novovich	director	C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS FL 32708